V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20056426 | 20175627 | 181 | null | Curative (C) | 2020-02-10 | 2020-03-01 | null | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100635586 |
| 20056776 | 20175628 | 1.75 | 95.85 | Adjuvant (A) | null | 2019-09-03 | null | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 101533361 |
| 20057775 | 20175629 | 1.77 | null | null | 2017-07-30 | 2017-07-30 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 101763723 |
| 20058008 | 20175630 | 1.74 | null | Neo-adjuvant (N) | 2018-09-16 | 2019-07-24 | null | 02 | N | MITOMYCIN INTRAVESICULAR | 101637630 |
| 20058058 | 20175631 | 1.72 | 35.3 | null | null | 2019-07-12 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 100370115 |
| 20059142 | 20175632 | 1.68 | 65 | Palliative (P) | 2019-04-18 | 2019-05-16 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100429515 |
| 20059322 | 20175633 | null | 73.6 | Palliative (P) | null | 2018-08-07 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 101565273 |
| 20059646 | 20175634 | 1.57 | 56.2 | null | 2017-06-23 | 2017-07-14 | null | N | null | SCALOP-2 TRIAL | 100357786 |
| 20059694 | 20175635 | 1.56 | 143.6 | null | 2019-05-20 | 2019-05-27 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101830387 |
| 20060232 | 20175637 | 0 | 67 | Palliative (P) | 2018-11-14 | 2018-12-12 | null | 02 | null | ABIRATERONE | 100376893 |
| 20060449 | 20175638 | 1.8 | null | Palliative (P) | 2017-08-20 | 2017-09-01 | null | 99 | N | LENALIDOMIDE | 100132558 |
| 20061625 | 20175639 | 1.72 | 82.4 | null | 2019-09-15 | 2020-01-29 | null | 02 | null | CISPLATIN | 100769388 |
| 20062614 | 20175642 | null | 83.6 | null | 2022-05-12 | 2022-05-12 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 101647803 |
| 20062872 | 20175643 | 1.83 | 60.4 | Palliative (P) | 2021-10-26 | 2021-11-10 | null | N | N | SUNITINIB | 101403551 |
| 20063021 | 20175644 | 1.76 | 70 | null | 2018-01-29 | 2018-02-22 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100357790 |
| 20063478 | 20175645 | 0 | null | Palliative (P) | 2016-10-05 | 2016-11-18 | null | 02 | Y | SUNITINIB | 100756910 |
| 20063853 | 20175646 | 1.7 | null | Adjuvant (A) | 2015-11-24 | 2016-01-29 | null | N | null | MITOMYCIN INTRAVESICULAR | 101153977 |
| 20064427 | 20175647 | 1.57 | 47.7 | Palliative (P) | 2017-08-24 | 2018-08-14 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101817598 |
| 20064608 | 20175648 | null | 57 | Palliative (P) | 2020-01-10 | 2020-01-10 | null | Y | N | SUNITINIB | 101795504 |
| 20065637 | 20175650 | 1.75 | 123.3 | null | 2019-08-27 | 2019-09-04 | null | 02 | null | CETUXIMAB + ENCORAFENIB | 100222094 |
| 20065823 | 20175651 | 1.79 | 81.6 | null | 2020-03-31 | 2020-04-04 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100850182 |
| 20065973 | 20175652 | 1.7 | 70 | Palliative (P) | 2016-11-20 | 2016-12-10 | null | null | N | MITOMYCIN INTRAVESICULAR | 101023012 |
| 20066571 | 20175653 | 1.68 | 69.6 | Disease modification (D) | null | 2021-12-16 | null | 99 | null | OCTREOTIDE | 100904687 |
| 20067991 | 20175655 | 1.73 | 71.5 | Adjuvant (A) | 2016-05-16 | 2016-05-28 | null | 02 | N | SCALOP-2 TRIAL | 100025544 |
| 20068190 | 20175656 | 1.85 | 65 | null | 2022-03-31 | 2022-05-19 | null | 2 | null | MITOMYCIN INTRAVESICULAR | 100553853 |
| 20069155 | 20175657 | null | null | Palliative (P) | 2020-08-03 | 2020-08-06 | null | 02 | N | NOT MATCHED | 101117936 |
| 20069324 | 20175658 | 1.68 | null | null | 2019-06-20 | 2019-06-28 | null | 02 | null | ABIRATERONE | 100851664 |
| 20070046 | 20175659 | 1.6 | 51.9 | null | 2021-08-09 | 2022-01-16 | CARBOPLATIN + FLUOROURACIL | 02 | N | CARBOPLATIN + FLUOROURACIL | 101510317 |
| 20070301 | 20175660 | 1.54 | 88.95 | Palliative (P) | 2019-04-22 | 2019-04-26 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100523326 |
| 20070382 | 20175661 | 1.73 | 80.2 | null | 2017-06-15 | 2017-06-26 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100340739 |
| 20070446 | 20175662 | 1.7 | 95.91 | Palliative (P) | 2021-09-28 | 2022-02-16 | null | 02 | null | OXALIPLATIN | 100303847 |
| 20073374 | 20175664 | 1.6 | 72 | Disease modification (D) | null | 2022-04-01 | null | 02 | N | MITOMYCIN INTRAVESICULAR | 101601864 |
| 20074761 | 20175666 | 1.71 | 18.9 | Neo-adjuvant (N) | 2019-11-02 | 2020-09-04 | Capecitabine + Cisplatin + RT | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 101565676 |
| 20078310 | 20175667 | 1.65 | 79.8 | Neo-adjuvant (N) | 2017-04-10 | 2017-04-12 | null | 2 | N | NOT MATCHED | 100647413 |
| 20078460 | 20175668 | 1.7 | 63 | Palliative (P) | 2016-06-15 | 2019-09-15 | null | null | N | EVEROLIMUS | 100966912 |
| 20078985 | 20175669 | 1.67 | 59.7 | Palliative (P) | 2019-05-02 | 2020-02-25 | null | 02 | N | LUTETIUM-177 | 100782911 |
| 20084150 | 20175670 | 1.68 | 90 | null | 2017-03-24 | 2017-04-06 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100861511 |
| 20084733 | 20175672 | 1.69 | 63 | Curative (C) | null | 2022-03-28 | null | 02 | N | NOT MATCHED | 100461725 |
| 20084757 | 20175673 | 1.78 | 86.6 | null | 2015-09-09 | 2019-04-20 | null | 02 | null | OXALIPLATIN | 100877133 |
| 20085579 | 20175675 | 1.88 | null | null | 2016-02-27 | 2016-04-28 | EVEROLIMUS | 02 | null | EVEROLIMUS | 100299022 |
| 20091883 | 20175677 | 1.73 | 66.5 | null | 2020-08-18 | 2020-08-26 | null | 2 | null | CISPLATIN + ETOPOSIDE | 101495733 |
| 20092250 | 20175678 | 0 | 78.3 | Palliative (P) | 2021-06-09 | 2021-06-21 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101555793 |
| 20095656 | 20175681 | 1.7 | 73.8 | Palliative (P) | 2021-10-24 | 2021-10-24 | null | 2 | N | CISPLATIN + ETOPOSIDE | 100480046 |
| 20102709 | 20175682 | 1.86 | 66 | null | 2018-10-29 | 2018-11-26 | null | N | null | MITOMYCIN INTRAVESICULAR | 100699180 |
| 20102753 | 20175683 | null | null | Palliative (P) | 2021-11-30 | 2022-03-08 | null | 01 | N | ENZALUTAMIDE | 101169511 |
| 20103311 | 20175684 | 1.7 | 120 | null | 2018-08-14 | 2020-02-21 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100700222 |
| 20104579 | 20175685 | 1.7 | 53.05 | null | 2019-06-27 | 2019-06-27 | null | 02 | null | SCALOP-2 TRIAL | 101197827 |
| 20104849 | 20175687 | null | null | null | 2019-12-06 | 2021-12-10 | null | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101653900 |
| 20110317 | 20175689 | 1.81 | 74 | Palliative (P) | 2022-04-28 | 2022-05-21 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 101063964 |
| 20110422 | 20175690 | 1.6 | null | Palliative (P) | null | 2022-05-16 | null | 02 | N | OXALIPLATIN | 101057072 |